Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether Urinary Kallikrein has an additional effect on enhancing collateral circulation in symptomatic intracranial atherosclerotic patients under clopidogrel and aspirin dual antiplatelet therapy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04325932
Study type Interventional
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact
Status Withdrawn
Phase Phase 4
Start date January 2016
Completion date July 2019

See also
  Status Clinical Trial Phase
Completed NCT04103034 - A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers Phase 1
Recruiting NCT05692882 - A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China N/A
Recruiting NCT05063630 - Intracranial Stenting in Non-acute Symptomatic Ischemic Stroke N/A
Completed NCT00200785 - Identifying the Anti-Blood-Clotting Compounds in Garlic N/A
Terminated NCT00000600 - Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up Phase 2
Not yet recruiting NCT06243133 - Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis Phase 4
Completed NCT02485275 - Stroke Imaging Package Study
Not yet recruiting NCT05653505 - Remote Ischemic Conditioning Combined With Endovascular Stenting for Symptomatic Intracranial Atherosclerotic Stenosis
Recruiting NCT05719883 - Evaluating the Safety and Efficacy of the Maurora® DES in ICAS N/A
Recruiting NCT05047172 - Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis Phase 3